Agios Pharmaceuticals Inc.
AGIO | NASDAQ
$34.87
+$0.92 (+2.71%)
Sep 22, 2026, 1:15 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -3.82 | 2.77 | -3.52 | -6.64 | -5.17 | -9.14 |
PEG Ratio | 0.02 | -0.01 | -0.07 | 0.20 | -0.15 | 0.32 |
PS Ratio | 29.21 | 51.14 | 46.21 | 108.04 | n/a | n/a |
PB Ratio | 1.32 | 1.21 | 1.53 | 1.40 | 1.54 | 7.48 |
P/FCF Ratio | -4.18 | -4.77 | -4.17 | -4.89 | -4.81 | -9.81 |
P/OCF Ratio | -4.23 | -4.79 | -4.19 | -4.97 | -4.88 | -10.28 |
OCF/S Ratio | -690.34 | -1.07K | -1.1K | -2.17K | n/a | n/a |
Debt / Equity Ratio | 0.03 | 0.04 | 0.09 | 0.08 | 0.08 | 0.26 |
Quick Ratio | 11.06 | 11.56 | 11.99 | 13.16 | 17.79 | 6.74 |
Current Ratio | 11.46 | 11.90 | 12.27 | 13.30 | 17.79 | 6.74 |
Asset Turnover | 0.04 | 0.02 | 0.03 | 0.01 | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -18.84 |
Return on Equity | -34.60% | 43.72% | -43.41% | -21.06% | 124.21% | -81.94% |
Return on Assets | -31.82% | 40.51% | -37.57% | -18.71% | 111.61% | -38.38% |
Return on Invested Capital | -38.18% | -24.99% | -44.28% | -32.70% | -27.24% | -43.86% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 78.67% | 88.59% | 64.57% | 88.03% | n/a | n/a |
Net Profit Margin | -764.01% | 1.85K% | -1.31K% | -1.63K% | n/a | n/a |
Pretax Profit Margin | -765.89% | 1.97K% | -1.31K% | -1.63K% | n/a | n/a |
Operating Profit Margin | -873.87% | -1.17K% | -1.46K% | -2.73K% | n/a | n/a |
FCF Margin | -698.33% | -1.07K% | -1.11K% | -2.21K% | n/a | n/a |
EBITDA Margin | -756.31% | 1.98K% | -1.29K% | -1.57K% | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove AGIO